×
For best experience we recommend to activate Javascript in your browser.
YARS2 antibody (C-Term)
YARS2
Reactivity: Human
WB, IHC (p)
Host: Rabbit
Polyclonal
RB14936
unconjugated
Product Details anti-YARS2 Antibody
(hide)
Target
See all YARS2 Antibodies
YARS2
(Tyrosyl-tRNA Synthetase 2, Mitochondrial (YARS2))
Binding Specificity
All epitopes for YARS2 antibodies
AA 399-427, C-Term
Reactivity
All reactivities for YARS2 antibodies
Human
Host
All hosts for YARS2 antibodies
Rabbit
Clonality
All clonalities for YARS2 antibodies
Polyclonal
Conjugate
All conjugates for YARS2 antibodies
This YARS2 antibody is un-conjugated
Application
All applications for YARS2 antibodies
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
Predicted Reactivity
M, Rat
Purification
This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
Immunogen
This YARS2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 399-427 amino acids from the C-terminal region of human YARS2.
Clone
RB14936
Isotype
Ig Fraction
Top Product
Discover our top product YARS2 Primary Antibody
Alternatives
(show)
Application Details
(hide)
Application Notes
WB: 1:1000. IHC-P: 1:10~50
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Expiry Date
6 months
References for anti-YARS2 antibody (ABIN1882153)
(hide)
Riley, Menezes, Rudinger-Thirion, Duff, de Lonlay, Rotig, Tchan, Davis, Cooper, Christodoulou : "Phenotypic variability and identification of novel YARS2 mutations in YARS2 mitochondrial myopathy, lactic acidosis and sideroblastic anaemia. " in: Orphanet journal of rare diseases , Vol. 8 , pp. 193 , (2014 ) (PubMed ).
Riley, Cooper, Hickey, Rudinger-Thirion, McKenzie, Compton, Lim, Thorburn, Ryan, Giegé, Bahlo, Christodoulou : "Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia--MLASA syndrome. " in: American journal of human genetics , Vol. 87 , Issue 1 , pp. 52-9 , (2010 ) (PubMed ).
Bonnefond, Frugier, Touzé, Lorber, Florentz, Giegé, Sauter, Rudinger-Thirion : "Crystal structure of human mitochondrial tyrosyl-tRNA synthetase reveals common and idiosyncratic features. " in: Structure (London, England : 1993) , Vol. 15 , Issue 11 , pp. 1505-16 , (2007 ) (PubMed ).
Target Details for YARS2
(hide)
Target
YARS2
(Tyrosyl-tRNA Synthetase 2, Mitochondrial (YARS2))
Alternative Name
YARS2 (YARS2 Products )
Synonyms
2210023C10Rik antibody, tyrRS antibody, CGI-04 antibody, RGD1311696 antibody, MLASA2 antibody, MT-TYRRS antibody, TYRRS antibody, tyrosyl-tRNA synthetase 2 (mitochondrial) antibody, tyrosyl-tRNA synthetase 2 antibody, Yars2 antibody, YARS2 antibody
Background
YARS2 catalyzes the attachment of tyrosine to tRNA(Tyr) in a two-step reaction: tyrosine is first activated by ATP to form Tyr-AMP and then transferred to the acceptor end of tRNA(Tyr).
Molecular Weight
53199
NCBI Accession
NP_001035526
UniProt
Q9Y2Z4
Recently viewed
(hide)